JULIA MARIE EASTLAND
CIK 1500189 · CEO & President · last filed 2026-05-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.14M
Companies
8
Total Filings
40
Lifetime Open-Market Net
$28.1K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LNTH | Director | 8,019 | $104.52 | $838.1K | $0 | 3 | 2026-05-18 |
| ZNTL | CEO & President | 80,022 | $3.75 | $300.1K | $28.1K | 5 | 2026-02-10 |
| DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Director | 16,071 | $15.50 | $249.1K | $0 | 5 | 2024-05-28 |
| Harpoon Therapeutics, Inc. (HARP) Delisted | President and CEO | 269,381 | $23.01 | $6.20M | $0 | 10 | 2024-03-11 |
| CALC | Director | 1,429 | $0.87 | $1.2K | $0 | 1 | 2023-03-27 |
| CalciMedica, Inc. (GRAY) Delisted | Director | — | $5.50 | — | $0 | 3 | 2022-06-03 |
| Cascadian Therapeutics, Inc. (CASC) Delisted | CFO & CBO | 5,237 | — | — | $0 | 4 | 2018-02-02 |
| Cascadian Therapeutics, Inc. (ONTY) Delisted | CFO & VP Corp. Dev. | 20,016 | — | — | $0 | 8 | 2016-05-19 |
Recent Filings · Page 4 of 4
40 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-09-20 | Cascadian Therapeutics, Inc. (CASC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-01-13 | Cascadian Therapeutics, Inc. (CASC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-05-19 | Cascadian Therapeutics, Inc. (ONTY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-09-28 | Cascadian Therapeutics, Inc. (ONTY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-12-16 | Cascadian Therapeutics, Inc. (ONTY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-12-16 | Cascadian Therapeutics, Inc. (ONTY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-12-14 | Cascadian Therapeutics, Inc. (ONTY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-12-05 | Cascadian Therapeutics, Inc. (ONTY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-12-03 | Cascadian Therapeutics, Inc. (ONTY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-11-10 | Cascadian Therapeutics, Inc. (ONTY) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 31–40 of 40
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.